NEOGENOMICS INC — Director's Dealing 2024

Dec 4, 2024

SEC Form 4/A — Form 4/A

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2024-05-11

Reporting Person: Smith Christopher M (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-11	Common Stock	M	48063	—	Acquired	650282	Direct
2024-05-11	Common Stock	F	18913	$14.86	Disposed	631369	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-11	Restricted Stock Unit	$0	M	48063	Disposed		Common Stock (48063)	Direct

Footnotes

F1: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

F2: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

F3: On May 14, 2024, the reporting person filed a Form 4 which inadvertently reported the number of shares of common stock received upon the vesting of certain of his RSUs twice. In fact, as reported in this amendment, the reporting person directly owned 631,369 shares of common stock after the vesting of 48,063 RSUs and reported withholding. The error effected the number of shares reported in Column 5 of Table I of each of the reporting person's subsequent filings on Form 4.

F4: On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three year anniversary dates of the grant date.

F5: Once vested, the shares of common stock are not subject to expiration.